EMPWR BV – Trademark Portfolio

Entity Type: 26

EMPWR BV holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 2 are pending. Notable registered marks include BARRA and BARRA NUTRITION.

Sluisweg 2 bus 11

B-9000 Gent

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EMPWR
EMPWR
Pending 2026
BARRA
BARRA
Registered 2023
EMPWR
EMPWR
Pending 2020

Trademark Classifications

EMPWR BV's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (3 filings)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

40
Treatment & Processing (1 filing)

Treatment of materials

Frequently Asked Questions

How many trademarks does EMPWR BV have?

EMPWR BV has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending.

What trademark classes does EMPWR BV file in?

EMPWR BV files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are EMPWR BV's most well-known trademarks?

EMPWR BV's registered trademark portfolio includes well-known marks such as BARRA and BARRA NUTRITION. These are among 2 currently registered trademarks in the portfolio.

What is EMPWR BV's trademark registration success rate?

EMPWR BV has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 2 applications are pending review.